DiaMedica Therapeutics (DMAC) EBT Margin (2018)
DiaMedica Therapeutics' EBT Margin history spans 1 years, with the latest figure at 266.0% for Q3 2018.
- For Q3 2018, EBT Margin changed N/A year-over-year to 266.0%; the TTM value through Jun 2019 reached 1798.0%, changed N/A, while the annual FY2025 figure was 3810.0%, 7561588.0% down from the prior year.
- EBT Margin reached 266.0% in Q3 2018 per DMAC's latest filing.
- In the past five years, EBT Margin ranged from a high of 266.0% in Q3 2018 to a low of 266.0% in Q3 2018.